South Asian consensus guideline: Use of GLP-1 receptor agonists during Ramadan: Update 2016 Revised Guidelines on the use of GLP-1A in Ramadan.
J Pak Med Assoc · 2016
Last updated 2026-05-28| Journal | J Pak Med Assoc, 2016 |
|---|---|
| Citations | 6 |
| Relative citation ratio | 0.31 |
| NIH percentile | 19 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity |
Abstract
This guidance is an update to the South Asian Consensus Guideline: Use of GLP1RA in Diabetes during Ramadan, published in the Indian Journal of Endocrinology and Metabolism in 2012. A five country working group has collated evidence and experience to suggest guidelines for the safe and rational use of glucagon-like peptide1 receptor agonists during Ramadan. The suggestions contained herewith are based upon recently published evidence as well as available basic pharmacological data.
Verbatim abstract via PubMed 27339589 ↗